Skip to content
K

Kanchan Vohra

Publications (4)

Sulfasalazine Improves Insulin Resistance and Endothelial Dysfunction in Metabolic Syndrome Patients

Kanchan Vohra, Pawan Krishan, Sudhir Varma & Harpreet Singh Kalra · Journal of Advances in Medicine and Medical Research · 2015

Aim: Metabolic syndrome (MetS) and all its components are independently characterized by the presence of low-grade chronic inflammation. The study aimed at controlling inflammation using sulfasalazine 500mg, once a day treatment in comparison to placebo in MetS patients. Study De...

Open access Research Article 10.9734/BJMMR/2016/20571

Association of Adipose-derived Hormones with Atherosclerosis Indices in Metabolic Syndrome Patients

Sikander Garg, Kanchan Vohra, Sudhir Varma, Harpreet Singh Kalra & Jasmeen . · Cardiology and Angiology: An International Journal · 2015

Aim: The study was aimed to determine the association of adipose derived hormones, adiponectin, leptin, and adiponectin/leptin (A/L) ratio with presence and degree of atherosclerosis in metabolic syndrome patients. Study Design: Open label, pilot, case-control study. Place and Du...

Open access Research Article 10.9734/CA/2015/17860

Estimating Glomerular Filtration Rate Using Full Age Spectrum Equation to Assess Kidney Function in Hypertensive Patients: A Cross-sectional Study

Balkar Chand, Lovleen Bhatia & Kanchan Vohra · Journal of Advances in Medical and Pharmaceutical Sciences · 2020

Background: Estimated glomerular filtration rate (eGFR) is accepted as the best indicator of kidney function and commonly assessed from serum creatinine (Cr) and cystatin C (Cys-C) based equations. The present cross-sectional, observational study aimed to assess eGFR using a new...

Open access Research Article 10.9734/jamps/2020/v22i730180

Sulfasalazine Induced DRESS Syndrome: A Review of Case Reports

Jasmeen ., Pawan Krishan, Sudhir Varma, Harpreet Kalra & Kanchan Vohra · Journal of Advances in Medicine and Medical Research · 2015

Introduction: Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) is designated as a lethal adverse drug effect with characteristic sign and symptoms such as skin rashes, fever, leukocytosis with eosinophilia or atypical lymphocytes, lymph node enlargement, and liver or ren...

Open access Research Article 10.9734/BJMMR/2016/20558